A Study to Develop a Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures

Overview

About this study

The purpose of this study is to investigate non-opioid alternatives to post-operative pain management following hip arthroscopy. This study aims to compare traditional narcotic intervention with a novel non-opioid pain regimen. 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients ≥ 16 years old.
  • Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN), and Mayo Clinic Orthopedics and Sports Medicine (Minneapolis, MN). 

Exclusion Criteria:

  • Patients with a medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
  • Substantial alcohol or drug abuse.
  • History of narcotics within 6 months of surgery.
  • Pregnancy.
  • Renal impairment.
  • Peptic ulcer disease.
  • GI bleeding.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Minneapolis, Minn.

Mayo Clinic principal investigator

Kelechi Okoroha, M.D.

Open for enrollment

Contact information:

Ciara Terry

(507) 538-3562

Terry.Ciara@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Kelechi Okoroha, M.D.

Open for enrollment

Contact information:

Ciara Terry

(507) 538-3562

Terry.Ciara@mayo.edu

More information

Publications

Publications are currently not available